CapsoVision, Inc (CV)
About CapsoVision, Inc
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $13.6M
- Net income
- -$25.3M
- Total assets
- $18.2M
- Market cap
- $359.2M
- Gross margin
- 52.9%
- Operating margin
- -188.3%
- Net margin
- -186.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $13.6M
- Cost of revenue
- $6.4M
- Gross profit
- $7.2M
- Operating expenses
- $32.7M
- Operating income
- -$25.5M
- Income tax
- $24.0K
- Net income
- -$25.3M
- EPS (basic)
- $-1.03
- EPS (diluted)
- $-1.03
Balance sheet
- Total assets
- $18.2M
- Current assets
- $16.7M
- Total liabilities
- $4.9M
- Current liabilities
- $4.4M
- Shareholders’ equity
- $13.3M
Cash flow
- Operating cash flow
- -$22.9M
- Investing cash flow
- -$90.0K
- Financing cash flow
- $23.6M
- Net cash flow
- $650.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $359.2M
- EPS (diluted)
- $-1.03
- Dividend yield
- 14.18%
- Shares outstanding
- 55.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 2, 2025
CapsoVision, Inc (CV) Stock Price
- Reported a net loss of $25.3M in FY2025.
- Revenue declined 96% from FY2011 to FY2025.
- Gross margin of 52.9%, net margin -186.8%.
- Trading 55% below its 52-week high.
- Pays a dividend yielding about 14.18% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CapsoVision, Inc.
Write a review
CapsoVision, Inc: frequently asked questions
Is CapsoVision, Inc an American company?
CapsoVision, Inc is a US-based company headquartered in Saratoga, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is CapsoVision, Inc headquartered?
CapsoVision, Inc is headquartered in Saratoga, California, United States.
Is CapsoVision, Inc publicly traded?
Yes — CapsoVision, Inc is a publicly traded company. Its stock trades under the ticker symbol CV on the NASDAQ.
What does CapsoVision, Inc do?
CapsoVision, Inc is an American Medical Devices company in the Health & Beauty sector.
